Page 7 - ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் Today - Breaking & Trending Today

Access to COVID-19 vaccines: Global approaches in a global crisis


Access to COVID-19 vaccines: Global approaches in a global crisis

Abstract
Following the extraordinarily rapid development of COVID‑19 vaccines, immunisation is underway in many OECD countries. However, demand will continue to outstrip supply for some time and currently, distribution is strongly skewed in favour of high-income countries. This both inequitable and inefficient. Directing vaccine to where need is greatest would maximise the number of lives saved and speed bringing the pandemic under control, by slowing transmission and reducing the likelihood of the emergence of viral variants of concern. Governments should therefore act now to accelerate vaccination globally, regardless of international borders, by reallocating supplies to areas of greatest need; continuing the scaling-up of production; ensuring that necessary logistics and health care infrastructure are in place; providing further financial and in-kind support to COVAX; and developing long-term st ....

United States , France General , United Kingdom , Noord Holland , New Zealand , South Africa , United Arab Emirates , City Of , Costa Rica , Saudi Arabia , Urlreferences Dagan , Doireferences Polack , Doireferences Bown , Astrazeneca Oxford , Urlreferences Lloyd Sherlock , Doireferences Mallapaty , Urlreferences Cohen , Urlreferences Cakmakli , Anhui Zhifei Longcom , Urlreferences Zhang , Institut Pasteur Themis Merck , Oxford Astrazeneca Chadox , Doireferences Burton , Doireferences Voysey , Doireferences Weekes , Doireferences Grenfell ,

Healthcare Ministry comments on production of QazVac vaccine


Healthcare Ministry comments on production of QazVac vaccine
21 April 2021 19:21
Share in:
NUR-SULTAN. KAZINFORM – Nurlybek Assylekov, head of the Medical and Pharmaceutical Control Department of the Healthcare Ministry of the Republic of Kazakhstan, said it is highly likely the homegrown QazVac vaccine is to be produced by the Research Institute for Biological Safety Problems, Kazinform correspondent reports.
Related news
Assylbekov told the press briefing at the Central Communications Service on Wednesday that up to 50,000 doses of QazVac vaccine may be delivered by late April.
He also added that the Kazakh side is negotiating the production of its vaccine in Turkey. In his words, the negotiations are not 100% complete. ....

Republic Of Kazakhstan , Yerlan Kiyasov , Nurlybek Assylekov , Healthcare Ministry , Research Institute For Biological Safety Problems , Central Communications Service On , Pharmaceutical Control Department , Research Institute , Biological Safety Problems , Central Communications Service , Healthcare Yerlan Kiyasov , குடியரசு ஆஃப் காஸக்ஸ்டாந் , சுகாதாரம் அமைச்சகம் , ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , மைய தகவல்தொடர்புகள் சேவை ஆன் , ஆராய்ச்சி நிறுவனம் , உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , மைய தகவல்தொடர்புகள் சேவை ,